Reaction Details Report a problem with these data
Target
Apoptosis regulator Bcl-2
Ligand
BDBM50202285
Substrate
n/a
Meas. Tech.
ChEMBL_441637 (CHEMBL891868)
Ki
70000±n/a nM
Citation
 Xing, C; Wang, L; Tang, X; Sham, YY Development of selective inhibitors for anti-apoptotic Bcl-2 proteins from BHI-1. Bioorg Med Chem 15:2167-76 (2007) [PubMed]  Article 
Target
Name:
Apoptosis regulator Bcl-2
Synonyms:
Apoptosis regulator Bcl-2 Protein | B-cell lymphoma 2 protein (Bcl-2) | BCL-2 | BCL2 | BCL2_HUMAN | Bcl-2 Protein
Type:
Homodimer or heterodimer
Mol. Mass.:
26269.11
Organism:
Homo sapiens (Human)
Description:
P10415
Residue:
239
Sequence:
MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK
  
Inhibitor
Name:
BDBM50202285
Synonyms:
5-(4-bromobenzylidene)-3-(1-morpholino-1-oxo-3-phenylpropan-2-yl)-4-oxo-2-thioxothiazolidine | CHEMBL243203
Type:
Small organic molecule
Emp. Form.:
C17H17BrN2O3S2
Mol. Mass.:
441.362
SMILES:
C[C@H](N1C(=S)S\C(=C/c2ccc(Br)cc2)C1=O)C(=O)N1CCOCC1
Structure:
Search PDB for entries with ligand similarity: